HC Wainwright & Co. Maintains Buy on Imunon, Raises Price Target to $14
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Emily Bodnar maintains a Buy rating on Imunon (NASDAQ:IMNN) and raises the price target from $12 to $14.
August 05, 2024 | 10:47 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. analyst Emily Bodnar maintains a Buy rating on Imunon and raises the price target from $12 to $14.
The raised price target and maintained Buy rating from a reputable analyst can positively influence investor sentiment and potentially drive the stock price higher in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100